Last reviewed · How we verify

NCT03153241

Subglottic Secretion Culture in Predicting Tracheal Microbial Flora

Completed Last updated 25 September 2024
What this trial tests

trial testing No intervention in Pneumonia in 100 participants. Completed in 20 November 2018.

Timeline
20 October 2017
Primary endpoint
20 October 2018
20 November 2018

Quick facts

Lead sponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date20 October 2017
Primary completion20 October 2018
Estimated completion20 November 2018
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

18 and older, any sex, with Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ventilator-associated pneumonia (VAP) continues to be a major cause of morbidity and mortality in the intensive care unit (ICU). Microaspiration of subglottic secretions accumulated above the endotracheal tube cuff is the primary route of bacterial entry into the lower respiratory tract.Therefore, removal of secretions from the subglottic spacehas been recommended as a preventive strategy to avoid microaspiration and VAP. In this context, whereas considerable literature exists on the use subglottic secretion drainage (SSD) in patients at risk for developing VAP, there is a lack of data on the bacterial growth in the subglottic fluid above the cuff. The primary objective of the study will be to assess the value of subglottic secretion culture in predicting microbial flora of endotracheal aspirate samplein patients admitted to our ICU and under invasive mechanical ventilation for at least 48 hours. Secondary end-point will be to estimate the predictive value of subglottic secretion culture in identifying bacterial pathogens in the sub-population of patients who will develop VAP.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study.
    Bello G, Bisanti A, Giammatteo V, Montini L, et al · · 2020 · cited 3× · PMID 32516641 · DOI 10.1016/j.jcrc.2020.05.013

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Pneumonia

Currently open trials in the same condition.

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03153241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing